Insight into psoriasis management: commercial perspectives for the U.S. psoriasis market.
Psoriasis is a chronic skin condition that has a significant impact on quality of life, self-esteem and comorbidities. Management of this condition is complicated and heavily influenced by psychosocial and economic realities. Addressing psychosocial and treatment education issues can be facilitated by use of the National Psoriasis Foundation. Localized disease is generally treated with topical treatment for which good generic medications are available. Somewhat higher priced branded vehicles are helpful for enhancing patients' treatment adherence, and may help avoid the need for far more toxic and expensive systemic treatment. Patients with extensive disease are best managed with phototherapy as a first-line option, and there is room for improvement in how insurers promote the use of this approach. Biologic treatments continue to offer new, safer options for patients with severe disease, albeit at higher cost. This review addresses practical issues in psoriasis management that would be of interest to organizations that are involved in the delivery of care for patients with psoriasis, such as managed care pharmacists and pharmaceutical companies that develop products for psoriasis.
Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Bryant
B
Tran
Steven R
SR
Feldman
D019468:Disease Management; D006801:Humans; D019458:Insurance Coverage; D011565:Psoriasis / Q000191:economics* / Q000628:therapy*; D012959:Socioeconomic Factors; D014481:United States